3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
2
Unknown
1
Terminated
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
5
Other hematologic neoplasm
3
Other solid neoplasm
2
Head & Neck
2
CNS
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Meningioma
1
Medulloblastoma
1
Cognitive Dysfunction
1
Interventions
Temozolomide
79
Magnetic Resonance Spectroscopy
68
Specimen Handling
45
Radiotherapy
42
Bevacizumab
29
Radiosurgery
27
Cyclophosphamide
27
Radiation
20
pembrolizumab
19
Blood Specimen Collection
19
fludarabine
16
Nivolumab
16
Irinotecan
15
Carboplatin
13
Biopsy
13
Etoposide
12
Vincristine
11
Pemetrexed
11
Lomustine
11
dinutuximab
9
Surgical Procedures, Operative
9
trametinib
8
abemaciclib
8
Ipilimumab
8
naxitamab
7
fluciclovine F-18
7
Watchful Waiting
7
Topotecan
7
Proton Therapy
7
Magnetic Resonance Imaging
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Tablets
×
CNS
×
Clear all
NCT06275919
2026-05-13
MIRAGE
Istituto Oncologico Veneto IRCCS
Phase 2
Recruiting
104 enrolled
NCT05230758
2026-05-01
Met Med Can
The Hospital for Sick Children
Phase 3
Recruiting
140 enrolled